Showing 1 - 1 results of 1 for search 'Renate Thalhammer', query time: 0.01s Refine Results
  1. 1
    Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial

    Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial by Miriam M. Moser, Renate Thalhammer, Christian Sillaber, Ulla Derhaschnig, Christa Firbas, Ulrich Jäger, Bernd Jilma, Christian Schoergenhofer

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: